Latest AM-Pharma News & Updates

See the latest news and media coverage for AM-Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AM-Pharma

Biopharmaceutical company developing therapies for rare diseases

am-pharma.com
Headquarters
Utrecht, Netherlands
Founded year
2002
Company type
Private company
Number of employees
28–50
Industry
Pharmaceuticals

Last updated

Latest news about AM-Pharma

Company announcements

AM-Pharma

AM-Pharma is acquired by Ambrose Healthcare

The UK-headquartered rare disease specialist takes over the ilofotase alfa programme for adults with hypophosphatasia, a patient group with unmet medical need.

AM-Pharma

AM-Pharma CEO Juliane Bernholz attends WCO-IOF-ESCEO 2026 congress

She will discuss musculoskeletal health and ilofotase alfa, its enzyme replacement therapy for adult hypophosphatasia, which has positive Phase 1b data and is Phase 3 ready.

Unlock all announcements with a

Media coverage

NRC

AM-Pharma closes million-dollar deal

The Utrecht-based pharmaceutical company AM-Pharma has closed a million-dollar deal with a Japanese industry colleague regarding the sales rights for a drug against acute kidney failure. The value of the...

Unlock all articles with a

Never miss news about AM-Pharma

Track AM-Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.